FDA Launches Major Review of CGMPs

FDA is set to revise CGMPs to encourage new manufacturing technologies and develop improved agency policies to ensure drug quality and safety.

Related Content:

Regulatory Oversight and CompliancePharmaceutical Technology-10-02-2002

Geopolitical Shifts Change Nature of Pharma Partnerships

FDA Grants Fast Track Designation to Q32 Bio Treatment for Alopecia Areata

CHMP Recommends argenx Treatment for Chronic Inflammatory Demyelinating Polyneuropathy